Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adults With Diabetic Gastroparesis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating CIN-102 (deudomperidone) for efficacy and safety in adults with diabetic gastroparesis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Gastroparesis

Drugs mentioned

• CIN-102

Snippet

Sponsor: CinDome Pharma, Inc. | Conditions: Diabetic Gastroparesis | Phase 2 | Status: COMPLETED